On a global scale, smoking-related mortality is set to rise from 3 million annually (1995 estimate) to 10 million annually by 2030, with 70% of these deaths occurring in developing countries (2). Smoking prevalence in men is currently highest in Pacific region countries, such as South Korea (68%), China (61%), and Japan (59%).
Among Americans aged 18 and older, 23.4% of men (25.1 million) and 18.5% of women (20.9 millions) are smokers, which puts them at increased risk of CHD (3). From 1997-2001, approximately 437,902 Americans died each year of smoking-related illnesses, and 34.7% of these deaths were related to cardiovascular complications (4). On average, male smokers die 13.2 years earlier than male non-smokers, whereas female smokers die 14.5 years earlier than non-smoking women (3). Moreover, it has been estimated that 35,052 non-smokers die from CHD each year in the United States as a result of exposure to environmental tobacco smoke (4).

Role of the Dysregulated Endocannabinoid System in Determining Cardiometabolic Risk by Vincenzo Di Marzo, PhD
More
What is the role of low HDL cholesterol in the elevated CHD risk of metabolic syndrome patients? By Philip J. Barter, MBBS, FRACP, PhD
More
Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008;32:283-91
More
Schematic representation of how smoking might add to several mechanisms linking obesity to cardiovascular disease
More